Larimar Therapeutics, Inc. (NASDAQ:LRMR) Receives Consensus Rating of “Moderate Buy” from Analysts
Shares of Larimar Therapeutics, Inc. (NASDAQ:LRMR – Get Free Report) have earned an average rating of “Moderate Buy” from the nine research firms that are presently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating and eight have issued a buy rating on the company. The [...]
